382 results on '"Ghysdael, Jacques"'
Search Results
2. Harnessing the MYB-dependent TAL1 5’super-enhancer for targeted therapy in T-ALL
3. P321: TNF-MEDIATED CELL DEATH: AN ACTIONABLE TARGET FOR IMMUNOTHERAPY IN T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA
4. Epstein-Barr Virus LMP1 Blocks p16INK4a-RB Pathway by Promoting Nuclear Export of E2F4/5
5. Growth Factor Receptors as Proto Oncogenes or Oncogene Products
6. The t(1;12)(q21;p13) Translocation of Human Acute Myeloblastic Leukemia Results in a TEL-ARNT Fusion
7. A TEL-JAK2 Fusion Protein with Constitutive Kinase Activity in Human Leukemia
8. Supplementary Figures 1 - 3, Table 1 from Triggering the TCR Developmental Checkpoint Activates a Therapeutically Targetable Tumor Suppressive Pathway in T-cell Leukemia
9. Supplementary Methods from AXL Inhibition in Macrophages Stimulates Host-versus-Leukemia Immunity and Eradicates Naïve and Treatment-Resistant Leukemia
10. Data from Novel Intergenically Spliced Chimera, NFATC3-PLA2G15, Is Associated with Aggressive T-ALL Biology and Outcome
11. Supplementary Figures from AXL Inhibition in Macrophages Stimulates Host-versus-Leukemia Immunity and Eradicates Naïve and Treatment-Resistant Leukemia
12. Supplementary Material from Novel Intergenically Spliced Chimera, NFATC3-PLA2G15, Is Associated with Aggressive T-ALL Biology and Outcome
13. Supplementary Methods, Figure Legends, Table Legend from Triggering the TCR Developmental Checkpoint Activates a Therapeutically Targetable Tumor Suppressive Pathway in T-cell Leukemia
14. Data from AXL Inhibition in Macrophages Stimulates Host-versus-Leukemia Immunity and Eradicates Naïve and Treatment-Resistant Leukemia
15. Data from Triggering the TCR Developmental Checkpoint Activates a Therapeutically Targetable Tumor Suppressive Pathway in T-cell Leukemia
16. Preclinical Evaluation of a Novel Small Molecule Inhibitor of LIM Kinases (LIMK) CEL_Amide in Philadelphia-Chromosome Positive (BCR::ABL+) Acute Lymphoblastic Leukemia (ALL)
17. The ETS Family of Transcriptional Regulators
18. Microenvironmental cues for T-cell acute lymphoblastic leukemia development
19. Lymphotoxin-β receptor in microenvironmental cells promotes the development of T-cell acute lymphoblastic leukaemia with cortical/mature immunophenotype
20. Oncogenic activation of the Notch1 gene by deletion of its promoter in Ikaros-deficient T-ALL
21. Control of CD8 T cell proliferation and terminal differentiation by active STAT5 and CDKN2A/CDKN2B
22. Identification of Human Granzyme B Promoter Regulatory Elements Interacting with Activated T-Cell-Specific Proteins: Implication of Ikaros and CBF Binding Sites in Promoter Activation
23. Characterization of a Hepatoma mRNA Transcribed from a Third Promoter of a 6-Phosphofructo-2-Kinase/Fructose-2,6-Bisphosphatase-Encoding Gene and Controlled by ets Oncogene-Related Products
24. Comparison of Constitutional and Tumor-Associated 11;22 Translocations: Nonidentical Breakpoints on Chromosomes 11 and 22
25. Integration of Bovine Leukemia Virus DNA in the Bovine Genome
26. A Phorbol Ester Response Element within the Human T-Cell Receptor β- Chain Enhancer
27. A Third Class of Avian Sarcoma Viruses, Defined by Related Transformation-Specific Proteins of Yamaguchi 73 and Esh Sarcoma Viruses
28. Cleavage of Four Avian Sarcoma Virus Polyproteins with Virion Protease p15 Removes gag Sequences and Yields Large Fragments That Function as Tyrosine Phosphoacceptors in vitro
29. NFAT transcription factors are essential and redundant actors for leukemia initiating potential in T-cell acute lymphoblastic leukemia
30. AXL Inhibition in Macrophages Stimulates Host-versus-Leukemia Immunity and Eradicates Naïve and Treatment-Resistant Leukemia
31. Epigenetic analysis of patients with T-ALL identifies poor outcomes and a hypomethylating agent-responsive subgroup
32. Interleukin-18 produced by bone marrow-derived stromal cells supports T-cell acute leukaemia progression
33. Targeting calcineurin activation as a therapeutic strategy for T-cell acute lymphoblastic leukemia
34. Identification and characterization of a PU.1/Spi-B binding site in the bovine leukemia virus long terminal repeat
35. The TEL-Jak2 oncoprotein induces Socs1 expression and altered cytokine response in Ba/F3 cells
36. Proteins of the ETS family with transcriptional repressor activity
37. SPI-1 transforming properties depend upon specifically activated forms of the EPOR
38. Characterization of a novel ETS gene, TELB, encoding a protein structurally and functionally related to TEL
39. IL-2 and long-term T cell activation induce physical and functional interaction between STAT5 and ETS transcription factors in human T cells
40. Characterization of the chronic myelomonocytic leukemia associated TEL-PDGFβR fusion protein
41. FLI-1 inhibits differentiation and induces proliferation of primary erythroblasts
42. NFAT Transcription Factors are Essential and Redundant Actors for Leukemia Initiating Potential in T-cell Acute Lymphoblastic Leukemia
43. Preclinical efficacy of humanized, non–FcγR-binding anti-CD3 antibodies in T-cell acute lymphoblastic leukemia
44. The TCR/CD3 complex in leukemogenesis and as a therapeutic target in T-cell acute lymphoblastic leukemia
45. Analysis of TEL proteins in human leukemias
46. Ets transcription factors bind and transactivate the core promoter of the von Willebrand factor gene
47. Cellular and viral trans-acting factors modulate N-myc2 promoter activity in woodchuck liver tumors
48. The TEL gene products: nuclear phosphoproteins with DNA binding properties
49. A TEL-JAK2 fusion protein with constitutive kinase activity in human leukemia
50. TYK2 is a key regulator of the surveillance of B lymphoid tumors
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.